We have also revealed that pharmacological application of FGF2 attenuates theprogression of liver fibrosis in an experimental murine BDL model, indicating that FGF2is a candidate anti-fibrotic agent for the treatment of liver fibrosis. This evidence concerns the gene FGF2 and Hepatic fibrosis.